Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Summary

The objective of this study is to investigate whether adding the study drug, NP137, to a patient's treatment regimen (before surgery and in combination with chemotherapy afterward) can alter the behavior of pancreatic cancer..

Timeline

Start

2026-09-01

Primary completion

2027-05-30

Completion

2032-09-30

Drugs

Indications